Global Cell Therapy Market, By Technology (Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology, Three-Dimensional Technology), Type (Autologous, Allogeneic), Cell Source (iPSCs, Bone Marrow, Umbilical Cord Blood-Derived Cells, Adipose Tissues, Neural Stem Cell), Application (Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Wounds & Injuries, Ocular, Others), End-User (Hospitals & Clinics, Regenerative Medicine Centers, Diagnostic & Research Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Cell Therapy Market
Cell therapy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 5.80% in the above-mentioned forecast period. Rising government investments in cell-based research drives the cell therapy market.
Cell therapy is a type of therapy in which live cells are injected into a patient for the treatment of a number of disorders. It involves the administration of somatic cell preparations for the treatment of diseases or traumatic damages. The main objective of this study is to provide long term treatment through a single injection of therapeutic cells. For example, T-Cells are injected for the treatment of cancer as they are capable of fighting cancer cells during the immunotherapy treatment course.
Rising incidence of chronic and infectious diseases is the vital factor escalating the market growth, also rising large number of oncology-related cell therapy clinical trials, rising GMP certifications for cell therapy production facilities, rising technological advancements in the field of cell therapy, increase in number of cell therapy clinical studies and increase in adoption of regenerative medicine are the major factors among others driving the cell therapy market. Moreover, rising emergence of iPSCs as an alternative to ESCs, rising focus on personalized medicine, rising public-private partnerships for the development of cell therapies and continuous emerging Asian markets will further create new opportunities for cell therapy market in the forecasted period of 2021-2028.
However, increased cost of cell-based research and low success rate and rising dearth of skilled professionals are the major factors among others which will obstruct the market growth, while survival of small players and new entrants will further challenge the growth of cell therapy market in the forecast period mentioned above.
This cell therapy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on cell therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Cell Therapy Market Scope and Market Size
Cell therapy market is segmented on the basis of technology, type, cell source, application and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of technology, the cell therapy market is segmented into somatic cell technology, cell immortalization technology, viral vector technology, genome editing technology, cell plasticity technology and three-dimensional technology.
- Based on type, the cell therapy market is segmented into autologous and allogeneic.
- Based on cells source, the cell therapy market is segmented into iPSCs, bone marrow, umbilical cord blood-derived cells, adipose tissues and neural stem cell.
- Based on application, the cell therapy market is segmented into musculoskeletal, cardiovascular, gastrointestinal, neurological, oncology, dermatology, wounds & injuries, ocular and others.
- The cell therapy market is also segmented on the basis of role of end-user into hospitals and clinics, regenerative medicine centers, diagnostic and research centers and others.
Cell Therapy Market Country Level Analysis
Cell therapy market is analysed and market size insights and trends are provided by country, technology, type, cell source, application and end-user as referenced above.
The countries covered in the cell therapy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the cell therapy market due to rising strong regulatory and financing support from the federal bodies for expansion of this arena in the U.S. as well as Canada in this region. Asia-Pacific is the expected region in terms of growth in cell therapy market due to rising availability of therapies at lower prices coupled with increasing awareness among the healthcare entities and patients pertaining to the potential of these therapies in chronic disease management in this region.
The country section of the cell therapy market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Cell therapy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for cell therapy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cell therapy market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Cell Therapy Market Share Analysis
Cell therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to cell therapy market.
The major players covered in the cell therapy market report are Vericel Corporation, Kolon TissueGene Inc., JCR Pharmaceuticals Co. Ltd., MEDIPOST, Osiris, Stemedica Cell Technologies Inc., NuVasive Inc., Fibrocell Science Inc., Cellectis, BioNTech IMFS, pluristem, Praxis Pharmaceutical, Genzyme Corporation, Advanced Tissue, Cells for Cells, PHARMICELL Co. Ltd, ANTEROGEN.CO.LTD., Novartis AG, GlaxoSmithKline plc, CELGENE CORPORATION, Bone Therapeutics, Cell Therapies, Celyad, Regen BioPharma, Cellular Therapeutics Ltd, TxCell, and Advancells. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Cell Therapy Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.